Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05171478 · ClinicalTrials.gov registry record
Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens
A clinical trial of Lung Cancer and Sarcoidosis, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05171478: Recruiting study of Lung Cancer and Sarcoidosis, sponsored by Johns Hopkins University.
NCT05171478 is a study of Lung Cancer and Sarcoidosis that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 20 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05171478, a study of Lung Cancer and Sarcoidosis, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study sets out to register imaging of small biopsy specimens obtained during bronchoscopy using full-field optical coherence tomography against standard histologic evaluation.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Full-field optical coherence tomography
Study Locations (1)
Maryland
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-12-09 |
| Est. Completion | 2026-12-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05171478
The ClinicalTrials.gov registry entry for NCT05171478 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Full-field optical coherence tomography is the first listed.
NCT05171478 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT05171478 about?
NCT05171478 is a clinical study titled "Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens". This study sets out to register imaging of small biopsy specimens obtained during bronchoscopy using full-field optical coherence tomography against standard histologic evaluation.
What is the current status of trial NCT05171478?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2021-12-09. Estimated completion is 2026-12-08.
What conditions does trial NCT05171478 study?
This clinical trial studies the following conditions: Lung Cancer, Sarcoidosis.
What interventions are being tested in trial NCT05171478?
The interventions under investigation include: Full-field optical coherence tomography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05171478?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05171478 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.